3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach

Administration›Physiological Systems and Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS 3E0M30Y
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

3E0M30Y is a billable ICD-10-PCS procedure code for Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under HIPEC (hyperthermic intraperitoneal chemotherapy). In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Chemotherapy.

Code Identity

ICD-10-PCS Code
3E0M30Y
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
Short Description
Introduce Hyperthermic Antneo in Periton Cav, Perc
Parent Code
3E0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/RegionMPeritoneal Cavity
5Approach3Percutaneous
6Substance0Antineoplastic
7QualifierYHyperthermic

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to 3E0M30Y as HIPEC (hyperthermic intraperitoneal chemotherapy). These index entries lead to this code:

HIPEC (hyperthermic intraperitoneal chemotherapy)
Direct entry for this code
Hyperthermic intraperitoneal chemotherapy (HIPEC)
Direct entry for this code
Lurbinectedin
Anatomy or device term that leads here
Abdominal cavity
Anatomy or device term that leads here
Gallbladder fossa
Anatomy or device term that leads here
ZEPZELCA(tm) (Lurbinectedin)
Anatomy or device term that leads here
Amivantamab Monoclonal Antibody
Anatomy or device term that leads here
RYBREVANT (tm) (Amivantamab Monoclonal Antibody)
Anatomy or device term that leads here
Introduction of substance in or on, Peritoneal Cavity
Leads to this code's table
Introduction of substance in or on, Peritoneal Cavity, Gas
Leads to this code's table
Introduction of substance in or on, Peritoneal Cavity, Antineoplastic
Leads to this code's table
Introduction of substance in or on, Peritoneal Cavity, Adhesion Barrier
Leads to this code's table

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM012
Chemotherapy
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 3E0M305 — Introduce Oth Antineoplastic in Periton Cav, Perc

Similar Procedure Codes

Questions About 3E0M30Y

Is 3E0M30Y a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for HIPEC (hyperthermic intraperitoneal chemotherapy)?

The ICD-10-PCS Alphabetic Index lists HIPEC (hyperthermic intraperitoneal chemotherapy) under code 3E0M30Y, Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach, billable on inpatient claims in fiscal year 2027.

What do the characters in 3E0M30Y mean?

The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character M is the BodySystem/Region (Peritoneal Cavity); the 5th character 3 is the Approach (Percutaneous); the 6th character 0 is the Substance (Antineoplastic); the 7th character Y is the Qualifier (Hyperthermic).